Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasting | 3 | 2020 | 278 | 1.070 |
Why?
|
| Energy Intake | 3 | 2020 | 493 | 0.930 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 175 | 0.750 |
Why?
|
| Patient Compliance | 1 | 2020 | 604 | 0.600 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2006 | 39 | 0.460 |
Why?
|
| Qc-SNARE Proteins | 1 | 2006 | 6 | 0.340 |
Why?
|
| Histidine | 1 | 2005 | 58 | 0.310 |
Why?
|
| Sulfadiazine | 1 | 2004 | 4 | 0.280 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2004 | 2 | 0.280 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 90 | 0.280 |
Why?
|
| Ureteral Calculi | 1 | 2004 | 8 | 0.280 |
Why?
|
| Mycobacterium Infections | 1 | 2004 | 61 | 0.280 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 89 | 0.260 |
Why?
|
| Mycobacterium | 1 | 2004 | 93 | 0.260 |
Why?
|
| Mobility Limitation | 2 | 2020 | 53 | 0.260 |
Why?
|
| Feeding Behavior | 2 | 2019 | 562 | 0.260 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 120 | 0.260 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 381 | 0.250 |
Why?
|
| Bacteremia | 1 | 2004 | 164 | 0.250 |
Why?
|
| Pilot Projects | 3 | 2020 | 1406 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 289 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1091 | 0.190 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 56 | 0.180 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2006 | 28 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2020 | 705 | 0.160 |
Why?
|
| Self Report | 1 | 2020 | 677 | 0.150 |
Why?
|
| Body Composition | 1 | 2020 | 738 | 0.150 |
Why?
|
| Vesicular Transport Proteins | 2 | 2006 | 78 | 0.150 |
Why?
|
| Eating | 1 | 2017 | 361 | 0.150 |
Why?
|
| Age Factors | 2 | 2020 | 3330 | 0.140 |
Why?
|
| Overweight | 1 | 2019 | 464 | 0.140 |
Why?
|
| Weight Loss | 1 | 2019 | 692 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1294 | 0.110 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 30 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 75 | 0.100 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2008 | 3 | 0.100 |
Why?
|
| Enterotoxins | 1 | 2008 | 86 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4549 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6778 | 0.090 |
Why?
|
| Travel | 1 | 2008 | 105 | 0.090 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 119 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 128 | 0.090 |
Why?
|
| Diarrhea | 1 | 2008 | 173 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 20025 | 0.080 |
Why?
|
| Micelles | 1 | 2006 | 36 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 908 | 0.080 |
Why?
|
| SNARE Proteins | 1 | 2006 | 35 | 0.080 |
Why?
|
| Escherichia coli Proteins | 1 | 2008 | 174 | 0.080 |
Why?
|
| Organothiophosphates | 1 | 2006 | 7 | 0.080 |
Why?
|
| Static Electricity | 1 | 2006 | 123 | 0.080 |
Why?
|
| Valine | 1 | 2006 | 91 | 0.080 |
Why?
|
| Leucine | 1 | 2006 | 111 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2008 | 333 | 0.080 |
Why?
|
| Tryptophan | 1 | 2006 | 130 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2006 | 305 | 0.080 |
Why?
|
| Humans | 11 | 2020 | 112249 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 598 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 214 | 0.070 |
Why?
|
| Cytosol | 1 | 2005 | 250 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 426 | 0.070 |
Why?
|
| Endosomes | 1 | 2005 | 140 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 527 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 596 | 0.070 |
Why?
|
| Protein Transport | 1 | 2005 | 455 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2005 | 640 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2005 | 335 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2006 | 543 | 0.060 |
Why?
|
| Transfection | 1 | 2005 | 996 | 0.060 |
Why?
|
| Lipids | 1 | 2006 | 619 | 0.060 |
Why?
|
| Stroke | 1 | 2010 | 916 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 1320 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 635 | 0.050 |
Why?
|
| Male | 4 | 2020 | 60715 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2228 | 0.050 |
Why?
|
| Female | 4 | 2020 | 62624 | 0.050 |
Why?
|
| Protein Binding | 1 | 2006 | 2112 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2029 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2017 | 54 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 54 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2664 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2020 | 240 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 81 | 0.040 |
Why?
|
| Immunoassay | 1 | 2017 | 105 | 0.040 |
Why?
|
| Gait | 1 | 2019 | 201 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 727 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 603 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2370 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 769 | 0.030 |
Why?
|
| Adult | 3 | 2010 | 31789 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 2427 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 2089 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 162 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 28676 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 7054 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 28 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 57 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 76 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8944 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1926 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 245 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 525 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2006 | 1740 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 11118 | 0.010 |
Why?
|
| United States | 1 | 2008 | 12170 | 0.010 |
Why?
|